84 related articles for article (PubMed ID: 339536)
21. [Recurrence prevention of papillomas of the bladder using lycurim instillation].
Zárandy B; Szabó J; Molnár I; Sallai Z; Simon Z; Légrády J
Z Urol Nephrol; 1984 Oct; 77(10):599-603. PubMed ID: 6549094
[TBL] [Abstract][Full Text] [Related]
22. [Intravesical chemotherapy of superficial bladder tumors].
Matsumura Y
Gan To Kagaku Ryoho; 1989 Feb; 16(2):193-8. PubMed ID: 2645832
[TBL] [Abstract][Full Text] [Related]
23. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
Huncharek M; McGarry R; Kupelnick B
Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
[TBL] [Abstract][Full Text] [Related]
24. Should all patients with non-muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective randomised multicentre study.
Gudjónsson S; Adell L; Merdasa F; Olsson R; Larsson B; Davidsson T; Richthoff J; Hagberg G; Grabe M; Bendahl PO; Månsson W; Liedberg F
Eur Urol; 2009 Apr; 55(4):773-80. PubMed ID: 19153001
[TBL] [Abstract][Full Text] [Related]
25. [Chemotherapy of bladder tumors. Indications and value of loco-regional and systemic application].
Pavone-Macaluso M
Urologe A; 1983 Sep; 22 Suppl():325-31. PubMed ID: 6195795
[TBL] [Abstract][Full Text] [Related]
26. [Postoperative intravesical instillation of THP for superficial bladder tumor: clinical results of prophylactic effects on the recurrence. Fukushima THP Research Group].
Aikawa K; Irisawa C; Muraki O; Yamaguchi O; Shiraiwa Y; Noguchi M; Koguchi M; Yokoyama J; Ito K; Kumakawa K
Gan To Kagaku Ryoho; 1992 Apr; 19(4):509-13. PubMed ID: 1558401
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant intravesical treatment with a standardized mistletoe extract to prevent recurrence of superficial urinary bladder cancer.
Elsässer-Beile U; Leiber C; Wetterauer U; Bühler P; Wolf P; Lucht M; Mengs U
Anticancer Res; 2005; 25(6C):4733-6. PubMed ID: 16334168
[TBL] [Abstract][Full Text] [Related]
28. [Intravesical therapy: Influence on superficial bladder cancer progression].
García Rodríguez J; Fernández Gómez JM; Escaf Barmadah S; Alvarez Múgica M; Rodríguez Robles L; Martín Benito JL; San Martín Blanco A; Regadera Sejas J
Arch Esp Urol; 2007; 60(1):31-5. PubMed ID: 17408169
[TBL] [Abstract][Full Text] [Related]
29. Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors.
Colombo R; Da Pozzo LF; Lev A; Salonia A; Rigatti P; Leib Z; Servadio C; Caldarera E; Pavone-Macaluso M
J Urol; 1998 Mar; 159(3):783-7. PubMed ID: 9474148
[TBL] [Abstract][Full Text] [Related]
30. Bacillus Calmette-Guérin therapy in stage Ta/T1 bladder cancer: prognostic factors for time to recurrence and progression.
Andius P; Holmäng S
BJU Int; 2004 May; 93(7):980-4. PubMed ID: 15142147
[TBL] [Abstract][Full Text] [Related]
31. [Intravesical chemotherapy of (2''R)-4'-O-tetrahydropyranyladriamycin in bladder tumor].
Masuda H; Hirose J; Suzuki K; Tajima A; Aso Y
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2411-4. PubMed ID: 3729494
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
33. Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma.
Ord JJ; Streeter E; Jones A; Le Monnier K; Cranston D; Crew J; Joel SP; Rogers MA; Banks RE; Roberts IS; Harris AL
Br J Cancer; 2005 Jun; 92(12):2140-7. PubMed ID: 15928663
[TBL] [Abstract][Full Text] [Related]
34. Intravesical therapy. A critical review.
Herr HW
Urol Clin North Am; 1987 May; 14(2):399-404. PubMed ID: 3554695
[TBL] [Abstract][Full Text] [Related]
35. [Infiltrating tumors of the bladder. Local response to systemic platinum-based chemotherapy].
Boccon-Gibod L; Adjiman S; Beuzeboc P; Steg A
Ann Urol (Paris); 1989; 23(4):285-8. PubMed ID: 2686541
[TBL] [Abstract][Full Text] [Related]
36. [Use of dibunol in bladder neoplasms].
Dul'kin LM
Urol Nefrol (Mosk); 1975; (2):57-8. PubMed ID: 1118988
[No Abstract] [Full Text] [Related]
37. [The effect of intravesical chemotherapy on superficial urinary bladder cancer].
Moriyama M; Kubota Y; Miura T; Shuin T; Noguchi S
Hinyokika Kiyo; 1983 Mar; 29(3):351-5. PubMed ID: 6203382
[TBL] [Abstract][Full Text] [Related]
38. [The prevention of the recurrence of stage pTa bladder tumors using intravesical instillation of BCG].
Wetzel O; Glemain P; Bouchot O; Guillonneau B; Baron M; Buzelin JM; Auvigne J
Prog Urol; 1993; 3(4):595-607. PubMed ID: 8401620
[TBL] [Abstract][Full Text] [Related]
39. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
[TBL] [Abstract][Full Text] [Related]
40. [Our experience with combined intravesical instillation therapy of superficial bladder tumor using Aclacinomycin-A (ACM) and cytosine arabinoside (CA)].
Tsugaya M; Iwase Y; Sakagami H; Washida H
Hinyokika Kiyo; 1987 Aug; 33(8):1180-4. PubMed ID: 3480687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
